| Schedule of Adjusted Condensed Cash Flow Statement |
The following table reflects the affected line items of the Condensed Consolidated Statements of Cash Flows and the adjustments to restated amounts. Net cash provided by financing activities; decrease in cash and cash equivalents; and cash and cash equivalents are also included to clarify that no restatement adjustments were made to those line items. The adjustments are as follows (in thousands):
|
|
Three Months Ended March 31, 2015
|
|
|
|
As Previously Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Condensed Consolidated Cash Flows (W&T including subsidiaries)
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable, accrued liabilities and other
|
|
(62,439
|
)
|
|
|
52,176
|
|
|
|
(10,263
|
)
|
|
Net cash provided by operating activities
|
|
742
|
|
|
|
52,176
|
|
|
|
52,918
|
|
|
Changes in operating assets and liabilities associated with investing activities
|
|
—
|
|
|
|
(52,176
|
)
|
|
|
(52,176
|
)
|
|
Net cash used in investing activities
|
|
(82,991
|
)
|
|
|
(52,176
|
)
|
|
|
(135,167
|
)
|
|
Net cash provided by financing activities
|
|
66,950
|
|
|
|
—
|
|
|
|
66,950
|
|
|
Decrease in cash and cash equivalents
|
|
(15,299
|
)
|
|
|
—
|
|
|
|
(15,299
|
)
|
|
Cash and cash equivalents, end of period
|
|
8,367
|
|
|
|
—
|
|
|
|
8,367
|
|
The following tables reflect the affected line items of the Condensed Consolidating Statements of Cash Flows contained within Note 13 – Supplemental Guarantor Information, and the adjustments to restated amounts. Net cash provided by financing activities, decrease in cash and cash equivalents, and cash and cash equivalents are also included to clarify that no restatement adjustments were made to those line items. The adjustments are as follows (in thousands):
|
|
Three Months Ended March 31, 2015
|
|
|
|
As Previously Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Condensed Consolidating Cash Flows (Parent Company)
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid expenses and other assets
|
|
7,924
|
|
|
|
(29,614
|
)
|
|
|
(21,690
|
)
|
|
Accounts payable, accrued liabilities and other
|
|
(92,436
|
)
|
|
|
52,176
|
|
|
|
(40,260
|
)
|
|
Net cash used in operating activities
|
|
(63,476
|
)
|
|
|
22,562
|
|
|
|
(40,914
|
)
|
|
Changes in operating assets and liabilities associated with investing activities
|
|
-
|
|
|
|
(22,562
|
)
|
|
|
(22,562
|
)
|
|
Net cash used in investing activities
|
|
(18,773
|
)
|
|
|
(22,562
|
)
|
|
|
(41,335
|
)
|
|
Net cash provided by financing activities
|
|
66,950
|
|
|
|
—
|
|
|
|
66,950
|
|
|
Decrease in cash and cash equivalents
|
|
(15,299
|
)
|
|
|
—
|
|
|
|
(15,299
|
)
|
|
Cash and cash equivalents, end of period
|
|
8,367
|
|
|
|
-
|
|
|
|
8,367
|
|
|
|
Three Months Ended March 31, 2015
|
|
|
|
As Previously Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Condensed Consolidating Cash Flows (Energy VI)
|
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid expenses and other assets
|
|
38,985
|
|
|
|
29,614
|
|
|
|
68,599
|
|
|
Net cash used in operating activities
|
|
64,218
|
|
|
|
29,614
|
|
|
|
93,832
|
|
|
Changes in operating assets and liabilities associated with investing activities
|
|
—
|
|
|
|
(29,614
|
)
|
|
|
(29,614
|
)
|
|
Net cash used in investing activities
|
|
(64,015
|
)
|
|
|
(29,614
|
)
|
|
|
(93,629
|
)
|
|
Net cash provided by financing activities
|
|
(203
|
)
|
|
|
—
|
|
|
|
(203
|
)
|
|
Decrease in cash and cash equivalents
|
|
-
|
|
|
|
—
|
|
|
|
-
|
|
|
Cash and cash equivalents, end of period
|
|
-
|
|
|
|
—
|
|
|
|
-
|
|
|